← Browse by Condition
Medical Condition

metastatic biliary tract cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06548412 Phase 1, Phase 2
Recruiting

CTX-009 With Gemcitabine, Cisplatin, and Durvalumab as First-line Therapy in Patients With Unresectable or Metastatic Biliary Tract Cancers

Enrollment
50 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →